WO2015011750A1 - Agent hydratant - Google Patents

Agent hydratant Download PDF

Info

Publication number
WO2015011750A1
WO2015011750A1 PCT/JP2013/069747 JP2013069747W WO2015011750A1 WO 2015011750 A1 WO2015011750 A1 WO 2015011750A1 JP 2013069747 W JP2013069747 W JP 2013069747W WO 2015011750 A1 WO2015011750 A1 WO 2015011750A1
Authority
WO
WIPO (PCT)
Prior art keywords
sugar
component
polyhydric alcohol
kluyveromyces
mass
Prior art date
Application number
PCT/JP2013/069747
Other languages
English (en)
Japanese (ja)
Inventor
豊明 小林
上原　静香
Original Assignee
株式会社コーセー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社コーセー filed Critical 株式会社コーセー
Priority to PCT/JP2013/069747 priority Critical patent/WO2015011750A1/fr
Priority to JP2015528256A priority patent/JP6382815B2/ja
Priority to CN201480032571.1A priority patent/CN105263471B/zh
Priority to PCT/JP2014/069088 priority patent/WO2015012198A1/fr
Priority to TW103124871A priority patent/TWI636797B/zh
Publication of WO2015011750A1 publication Critical patent/WO2015011750A1/fr
Priority to HK16101803.7A priority patent/HK1213786A1/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Definitions

  • the present invention relates to a humectant.
  • Moisturizing ingredients are blended in topical skin preparations, cosmetics, quasi-drugs, and the like for the purpose of adjusting moisture on the skin surface to give moist and moist feeling to the skin and hair.
  • the skin barrier function tends to decrease.
  • skin troubles such as dry skin, wrinkles, and rough skin are likely to occur, and improvement of skin inflammation is delayed. For this reason, increasing and retaining the moisture in the stratum corneum has been expected to be used for various purposes because it leads to keeping the skin soft, elastic and protecting the dermis.
  • a moisturizing component for example, glycerin having high hygroscopicity has been used.
  • these components are easily affected by the surrounding humidity, and do not exhibit a sufficient effect on dry skin, but also have the problem of taking away moisture from the skin and promoting drying. For this reason, at present, attention is focused mainly on biological component-derived or biologically similar components.
  • NMF NATURAL MOISTURIZING FACTOR
  • amino acids eg, glycine, ⁇ -alanine, etc.
  • high molecular compounds such as hyaluronic acid, soluble collagen, ceramide, etc.
  • Patent Document 1 proposes a humectant containing lysyl- ⁇ -alanine or a salt thereof.
  • the present invention is intended to provide an excellent moisturizing agent in view of such circumstances.
  • the present inventor has (A) a sugar fermented product obtained from yeast belonging to the genus Kluyveromyces, and (B) a specific gravity at 20 ° C. of 0.93 or more. It has been found that an excellent moisturizing effect can be obtained by using together with a monohydric alcohol, and the present invention has been completed.
  • the present invention provides the following components (A) and (B): (A) Sugar fermented product from yeast of the genus Kluyveromyces (B) A humectant containing a polyhydric alcohol having a specific gravity at 20 ° C. of 0.93 or more is provided.
  • the polyhydric alcohol of component (B) may be a polyhydric alcohol having a specific gravity at 20 ° C. of 1.01 or more.
  • the polyhydric alcohol of component (B) may be one or more selected from glycerin, propanediol, propylene glycol, and dipropylene glycol.
  • an excellent moisturizing agent can be provided.
  • the moisturizing agent of the present disclosure contains, as active ingredients, component (A) a sugar fermented product of Kluyveromyces yeast and component (B) a polyhydric alcohol having a specific gravity at 20 ° C. of 0.93 or more. Is.
  • component (A) sugar fermented product of yeast of the genus Kluyveromyces (hereinafter also referred to as “component (A) sugar fermented product”) used in the present disclosure will be described.
  • the “Kluyveromyces yeast” used in the present disclosure is not particularly limited, and one or more of the following exemplified yeast species can be selected and used.
  • yeast examples include, for example, Kluyveromyces thermotolerans, Kluyveromyces africanus, Kluyveromyces fragilis, Kluyveromyces lactis, Kluyveromyces phaffii, Kluyveromyces waltii, Kluyveromyces wickerhamii, Kluyveromyces wickerhamii, Kluyveromyces warrowhamii Is mentioned.
  • Kluyveromyces thermotolerans Kluyveromyces thermotolerans
  • Kluyveromyces lactis Kluyveromyces lactis
  • Kluyveromyces fragilis more preferably Kluyveromyces fragilis.
  • Tolerance Keluyveromyces thermotolerans
  • These yeasts have long been used for producing dairy products such as cheese and yogurt, wine, and fermented foods such as pickles.
  • Kluyveromyces thermotolerance has been reported as a lactic acid-producing yeast isolated from wine brewing and plum jam fermentation products along with its biochemical and physiological properties (Reference 1: The Yeasts.A). Taxonomic Study, 4th ed. Elsevier Science BV, Amsterdam. 240-241 (1998)).
  • Kluyveromyces thermotolerans examples include Kluyveromyces thermotolerans MA KT (NITE BP-1420).
  • the Kluyveromyces genus yeast used in the present disclosure is an extremely safe microorganism for the human body and can also eat sugar as a fermentation raw material. Therefore, the component (A) sugar of the present disclosure Fermented products are considered to be highly safe.
  • the “sugar” used as a raw material for the component (A) fermented sugar of the present disclosure is not particularly limited, and those containing sucrose are preferable.
  • the “sugar” may be in any form such as powder or liquid.
  • sugar derived from sugarcane is preferable, and sugarcane sugar obtained from sugarcane squeezed juice is more preferable.
  • sugars derived from sugarcane include unpurified sugars such as Wasanbon, molasses, black honey, honey-containing sugar, crude sugar, brown sugar, and the like; and refined sugars such as upper white sugar and granulated sugar. More than one species can be selected.
  • unpurified sugar that has not been purified to upper white sugar is preferred, and among the unpurified sugars, brown sugar is preferred.
  • Brown sugar is produced by heating and concentrating sugarcane squeezed juice, and is preferably not subjected to separation and purification of sugar.
  • the “sugarcane” of the present disclosure is a plant belonging to the genus Sugarcane (sugar cane, scientific name: Saccharum officinarum), and is also called sweet potato.
  • the component (A) sugar fermented product of the present disclosure is preferably a fermented product obtained by culturing Kluyveromyces yeast in a sugar-containing medium.
  • the content of sugar in the sugar-containing medium of the present disclosure is not particularly limited, but is preferably 3 to 15% by mass, more preferably 4 to 8% by mass.
  • the sugar-containing medium of the present disclosure is preferably a liquid.
  • the sugar-containing liquid medium include an aqueous sugar solution obtained by mixing the above-described sugar and water. The water is not particularly limited.
  • the sugar-containing medium preferably contains medium components (for example, a carbon source, a nitrogen source, inorganic salts, etc.) usually used for yeast in terms of improving the productivity of the fermented product.
  • medium components for example, a carbon source, a nitrogen source, inorganic salts, etc.
  • the culture method of the Kluyveromyces genus yeast is not particularly limited as long as it is a culture method usually used for yeast, and can follow a known method (for example, see Reference 1). For example, shaking culture, aeration culture, stationary culture, stirring culture and the like can be mentioned. Moreover, any of a batch type and a continuous type may be sufficient. These can be performed alone or in combination of two or more.
  • the culture conditions (for example, aerobic, anaerobic, pH in the medium, dissolved oxygen, culture temperature, culture time, etc.) of the Kluyveromyces yeast are not particularly limited, and can be appropriately selected according to the purpose. it can.
  • the component (A) fermented sugar of the present disclosure is preferably prepared by aerobic culture in a sugar-containing medium inoculated with pre-cultured Kluyveromyces yeasts. At this time, it is preferable to add 1% of the preculture solution to the sugar-containing medium. At this time, it is preferable to perform the aerobic culture at a medium pH of 5 to 7 at 15 to 35 ° C. for 1 to 3 days. As the preferred culture, it is desirable to perform shaking culture or stirring culture under aerobic conditions. In the case of aerobic conditions, air (about 20% by volume of oxygen) treated with a sterilization filter may be used.
  • the preparation of the present disclosure does not actively perform ethanol fermentation as in alcoholic beverage production, but the ethanol concentration in the sugar fermentation product after the preparation is less than 1% by mass (preferably 0.1% by mass or less) ) Is preferable in terms of the moisturizing effect.
  • the component (A) sugar fermented product of the present disclosure can be used as it is or after it is dried.
  • cells of Kluyveromyces genus yeast may be removed by a conventional method such as centrifugation or membrane treatment.
  • the component (A) fermented sugar product of the present disclosure may be a diluted solution, a concentrated solution, or a dried product, and may be a separated product or a purified product according to the purpose.
  • a physiological saline solution may be used, and when drying, a freeze drying method or a spray drying method may be used.
  • component (B) polyhydric alcohol having a specific gravity at 20 ° C. (g / mL at 20 ° C.) of 0.93 or more” (hereinafter also referred to as “component (B) polyhydric alcohol”) used in the present disclosure will be described. .
  • the component (B) of the present disclosure can be prepared by selecting one or more of the following examples of the component (B) polyhydric alcohol.
  • Component (B) “polyhydric alcohol having a specific gravity of 0.93 or more at 20 ° C.” of the present disclosure includes methylene glycol, glycol (ethylene glycol), propylene glycol, propanediol (1,3-propanediol), diethylene glycol Coal, methylenepropanediol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, 2,3-butanediol, 1,2-pentanediol, 1,3-pentanediol, 1, 4-pentanediol, 1,5-pentanediol, 2,4-pentanediol, 1,2-cyclopentanediol, 1,3-cyclopentanediol, neopentyl glycol, isopentyldiol, aminoethylpropanediol, 1, 2-hexanediol, 1,6-hex
  • the specific gravity (g / mL at 20 ° C.) of the component (B) polyhydric alcohol of the present disclosure is preferably 1.01 or more, more preferably 1.03 or more. When used together, the moisture retention can be further improved, which is preferable. Moreover, the specific gravity (g / mL at 20 ° C.) of the polyhydric alcohol of the present disclosure is preferably 2 or less.
  • the alcohol valence of the polyhydric alcohol is preferably 2 to 4, more preferably 2 to 3.
  • the component (B) polyhydric alcohol preferably has 6 or less carbon atoms, more preferably 2 to 4 carbon atoms.
  • the refractive index of the component (B) polyhydric alcohol is preferably 1.3 to 1.6, more preferably 1.4 to 1.5.
  • component (B) polyhydric alcohols propylene glycol, propanediol, 1,2-butylene glycol, 1,3-butylene glycol, 1,2-pentanediol, dipropylene glycol and glycerin are preferred. Furthermore, propylene glycol, propanediol, dipropylene glycol and glycerin are more preferable among the components (B) from the viewpoint of improving moisture retention.
  • the “specific gravity at 20 ° C.” of the polyhydric alcohol is a value measured by the specific gravity measurement method No. 1 described in the Ministry of Health, Labor and Welfare: Quasi-drug raw material standard 2006 (published by Yakuji Nipposha).
  • the “refractive index at 20 ° C.” of the polyhydric alcohol is a value measured by a refractive index measurement method described in Japan Ministry of Health, Labor and Welfare: Quasi-drug raw material standard 2006 (published by Yakuji Nippo).
  • the preparation of the humectant of the present disclosure combines the component (A) sugar fermented product and the component (B) polyhydric alcohol, and therefore, these may be mixed. When combining these, it is preferable to use a sugar fermentation liquid (preferably an aqueous solution) as the component (A) sugar fermentation product.
  • a sugar fermentation liquid preferably an aqueous solution
  • the content ratio of the component (A) sugar fermented product and the component (B) polyhydric alcohol in the moisturizing agent of the present disclosure (parts by mass of dry solids: parts by mass) is not particularly limited, but from the viewpoint of improving moisturizing properties. The ratio is preferably 0.09: 0.5 to 0.09: 30, more preferably 0.09: 1 to 0.09: 20, and still more preferably 0.09: 5 to 0.09: 10.
  • the content of the component (B) polyhydric alcohol in the moisturizing agent is preferably 1 to 30% by mass, more preferably 5 to 20% by mass. In addition, it is possible to adjust so that it may become 100 mass% of humectants using water.
  • the form of the moisturizing agent of the present disclosure to be obtained is not particularly limited, but liquid or semi-solid is preferable.
  • the moisture retention can be dramatically improved as compared with the case where each component is used alone. Admitted. Therefore, since the mixture of the component (A) and the component (B) has a very excellent moisturizing property, it may be used for moisturizing and various preparations intended for use for moisturizing. It can also be used to produce these various formulations. Moreover, since the combination of the said component (A) and the said component (B) has the outstanding moisturizing property, it is used for the method for aiming at prevention, improvement, and / or treatment of various symptoms, conditions, etc. regarding skin by moisturizing. can do.
  • the various symptoms and conditions include rough skin, wrinkle formation, skin aging, xeroderma, dandruff, and the like.
  • the combination of the said component (A) and the said component (B) can give a moist feeling to a target object (for example, skin, hair, foodstuff, etc.).
  • a target object for example, skin, hair, foodstuff, etc.
  • the combination of the said component (A) and the said component (B) can be used in order to give a moist feeling and a feeling of unity to hair, and, thereby, can suppress hairiness.
  • the component (A) sugar fermented product and the component (B) polyhydric alcohol are used in order to improve or impart moisturizing properties, such as external preparations for skin, cosmetics, quasi drugs, pharmaceuticals, foods and functional foods.
  • the moisturizing agent of the present disclosure can be the above-mentioned external preparation for skin, cosmetics, foods and the like. Moreover, you may make these preparations contain the moisturizer containing the said component (A) of this indication, and the said component (B).
  • the humectant of the present disclosure or the component (A) fermented sugar and the component (B) polyhydric alcohol are particularly suitable for use in external preparations for skin, cosmetics, quasi drugs, etc.
  • a preparation to be contacted by application or the like is preferable.
  • skin external preparations and cosmetics include skin lotions, emulsions (oil-in-water type, etc.), creams (oil-in-water type), pack cosmetics, liquid foundations, ointments, hair nourishing agents, hair protectants and the like.
  • the content of the component (A) fermented sugar in the preparation of the present disclosure is preferably 0.001 to 0.095% by mass, more preferably as a dry solid content, from the viewpoint of the stability of the preparation and moisture retention. It is 0.005 to 0.05 mass%, more preferably 0.001 to 0.02 mass%.
  • the content of the component (B) polyhydric alcohol in the preparation of the present disclosure is preferably 1 to 50% by mass, more preferably 5 to 40% by mass, and further preferably 10 to 30% from the viewpoints of safety and moisture retention. % By mass.
  • the content ratio of the component (A) sugar fermented product and the component (B) polyhydric alcohol in the formulation of the present disclosure is not particularly limited, but the stability and moisture retention of the formulation From this viewpoint, it is preferably 0.01: 5 to 0.01: 500, more preferably 0.01: 10 to 0.01: 300, and still more preferably 0.01: 20 to 0.01: 200.
  • moisturizer of the present disclosure and the preparation of the present disclosure are necessary as long as the effects of the present technology are not impaired in addition to the component (A) fermented sugar and the component (B) polyhydric alcohol of the present disclosure.
  • optional components may be used in combination.
  • components may be pharmaceutically acceptable components, such as preservatives, cell activators, antioxidants, humectants, UV inhibitors, solvents (water, alcohols, etc.), oils, interfaces Activator, Thickener, Powder, Chelating agent, pH adjuster, Emulsifier, Stabilizer, Colorant, Brightener, Flavoring agent, Flavoring agent, Excipient, Binder, Disintegrant, Lubricant, Dilution Agents, osmotic pressure adjusting agents, fragrances and the like, and these may be added according to the intended preparation.
  • the form of the preparation is not particularly limited, and may be any form such as liquid, paste, gel, solid, and powder.
  • this technique can also employ
  • humectant according to any one of [1] to [3], wherein the polyhydric alcohol of component (B) is a polyhydric alcohol having a specific gravity at 20 ° C. of 1.01 or more.
  • the polyhydric alcohol of component (B) is one or more selected from glycerin, propanediol, propylene glycol, and dipropylene glycol. The humectant described.
  • the yeast belonging to the genus Kluyveromyces is one selected from Kluyveromyces thermotolerans, Kluyveromyces lactis and Kluyveromyces fragilis
  • the component (A) fermented sugar product is a fermented product obtained by culturing Kluyveromyces yeast in a sugar (preferably unpurified sugar) -containing medium.
  • the humectant according to any one of the above.
  • ⁇ Preparation Example 1 Preparation of brown sugar fermentation broth by Kluyveromyces thermotolerans> [Pre-culture] Liquid culture of Kluyveromyces thermotolerance MA KT (NITE BP-1420) was performed using YPD medium (pH 6.0). One platinum loop of the liquid culture solution was taken and inoculated into a YM medium (solid medium), and precultured at 25 ° C. for 2 days.
  • YPD Yeast Extract-Peptone- Dextrose
  • YM Yeast Mold
  • MA KT (NITE BP-1420) is a country of origin: Japan / source: collected from sap, classified as Lachancea (Kluyveromyces) thermotolerans based on morphology and bacteriological properties, and named MA KT It is. The strain was deposited on September 13, 2012 at the depository: 2-5-8, Kazusa Kamashichi, Kisarazu City, Chiba Prefecture 292-0818, Japan, and the National Institute of Technology and Technology (NPMD). It is what.
  • Examples 1 to 7 and Comparative Examples 1 and 2 Production of moisturizing agent>
  • the brown sugar fermentation broth prepared in Preparation Example 1 was mixed so that the solid content concentration was 0.09% by mass and each polyhydric alcohol shown in Table 1 was 10% by mass, and Examples 1 to 7 and Comparative Examples 1 to 2 were mixed. A humectant was produced.
  • the sample which mixed the purified water instead of the brown sugar fermentation liquid was also prepared.
  • the specific gravity was measured by the specific gravity measurement method No. 1 described in Japan Ministry of Health, Labor and Welfare: Quasi-drug raw material standard 2006 (published by Yakuji Nippo Co., Ltd.).
  • the refractive index was measured by the refractive index measurement method described in the Ministry of Health, Labor and Welfare: quasi-drug raw material standard 2006 (published by Yakuji Nippo Co., Ltd.). No symbol: Quasi-drug raw material standard 2006 # 1 MERCK INDEX ELEVENTH EDITION # 2 Chemical Handbook Basics I (The Chemical Society of Japan, revised 4th edition) # 3 Cosmetics Handbook (Nikko Chemicals) # 4 Chemical book
  • the moisturizing effect was measured by the following method. After washing the inner part of the forearm, the measurement site (2 cm ⁇ 2 cm) was marked. It was acclimatized for 20 minutes under an air temperature of 20 ° C. and a humidity of 50%, and the moisture content was measured with Skicon200 (IBSCo. Ltd.). This value was taken as the value before coating. Thereafter, 100 ⁇ L of the sample was impregnated into a 2 cm ⁇ 2 cm tissue paper, and then placed on the measurement site and allowed to stand for 5 minutes. The tissue paper was peeled off and the sample was applied to the skin with a finger. The value obtained by measuring the moisture content with Skicon200 (IBSCo. Ltd.) 60 minutes after the completion of coating was taken as the value after 60 minutes.
  • FIGS. S is the time when the mixed solution of brown sugar fermented liquid and polyhydric alcohol is applied
  • w is the time when the mixed liquid of brown sugar fermented liquid and purified water is applied
  • the water content after 60 minutes of application is A
  • the water content before coating B As / Bs and Aw / Bw at this time are shown in FIG.
  • (As / Bs) / (Aw / Bw) is shown in FIG.
  • Comparative Example 2 in which brown sugar fermented liquid and purified water were combined, the amount of water was lower than before application, but the brown sugar fermented liquid was combined with polyhydric alcohol having a specific gravity of 0.93 or higher at 20 ° C.
  • the water content was kept high until 60 minutes after application. That is, by combining a sugar fermentation product from yeast of the genus Kluyveromyces with a polyhydric alcohol having a specific gravity of 0.93 or higher at 20 ° C., the moisture content is dramatically increased compared to the case where each is used alone. It was observed that the sex was improved. It was recognized that the moisture retention was significantly improved when the specific gravity of the polyhydric alcohol exceeded 1.0065.
  • Latex (Ingredient) (mass%) 1. Polyoxyethylene (20) sorbitan monooleate 1.0 2. Sorbitan sesquioleate 0.5 3. Glyceryl trioctanoate 0.5 4). Jojoba oil 0.5 5. Squalane 0.5 6). 6. Purified water remaining amount Edetate disodium 0.1 8). Methylparaben 0.2 9. Phenoxyethanol 0.5 10. Glycerin 5.0 11. Propanediol 1.0 12 Propylene glycol 2.0 13. Sodium lactate 0.5 14. 2-O- ⁇ -D-glucosyl-L-ascorbic acid 1.0 15. Brown sugar fermentation broth of Preparation Example 1 (solid content concentration 0.1% by mass) 20.0 16. Xanthan gum 0.05 17.
  • MA KT (NITE BP-1420) strain / Classification: Lachancea (Kluyveromyces) thermotolerans / Depositary: 292-0818, Kisarazu City, Chiba Pref. (NPMD) / Contract date: September 13, 2012.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention vise à fournir un excellent agent hydratant. À cet effet, la présente invention concerne un agent hydratant comportant : un produit de fermentation du sucre (A) obtenu au moyen d'une levure appartenant au genre Kluyveromyces ; et un alcool polyhydrique (B) ayant une gravité spécifique à 20°C d'au moins 0,93. L'alcool polyhydrique (B) peut avoir une gravité spécifique à 20°C d'au moins 1,01. En outre, l'alcool polyhydrique (B) peut être au moins un parmi la glycérine, le propanediol, le propylène glycol, et le dipropylène glycol.
PCT/JP2013/069747 2013-07-22 2013-07-22 Agent hydratant WO2015011750A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PCT/JP2013/069747 WO2015011750A1 (fr) 2013-07-22 2013-07-22 Agent hydratant
JP2015528256A JP6382815B2 (ja) 2013-07-22 2014-07-17 保湿剤
CN201480032571.1A CN105263471B (zh) 2013-07-22 2014-07-17 保湿剂
PCT/JP2014/069088 WO2015012198A1 (fr) 2013-07-22 2014-07-17 Agent hydratant
TW103124871A TWI636797B (zh) 2013-07-22 2014-07-21 moisturizer
HK16101803.7A HK1213786A1 (zh) 2013-07-22 2016-02-18 保濕劑

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/069747 WO2015011750A1 (fr) 2013-07-22 2013-07-22 Agent hydratant

Publications (1)

Publication Number Publication Date
WO2015011750A1 true WO2015011750A1 (fr) 2015-01-29

Family

ID=52392836

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/JP2013/069747 WO2015011750A1 (fr) 2013-07-22 2013-07-22 Agent hydratant
PCT/JP2014/069088 WO2015012198A1 (fr) 2013-07-22 2014-07-17 Agent hydratant

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/069088 WO2015012198A1 (fr) 2013-07-22 2014-07-17 Agent hydratant

Country Status (5)

Country Link
JP (1) JP6382815B2 (fr)
CN (1) CN105263471B (fr)
HK (1) HK1213786A1 (fr)
TW (1) TWI636797B (fr)
WO (2) WO2015011750A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6644964B2 (ja) * 2015-04-17 2020-02-12 クラシエホームプロダクツ株式会社 化粧料
CN108186535A (zh) * 2018-03-12 2018-06-22 黑龙江军门现代农业发展有限公司 一种红糖蚕丝面膜
KR102271426B1 (ko) * 2020-08-27 2021-07-01 백은주 수용성 물질로만 이루어진 마사지 컨디셔닝제

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000159653A (ja) * 1998-11-24 2000-06-13 Nonogawa Shoji Kk 皮膚外用剤
FR2826576A1 (fr) * 2001-06-27 2003-01-03 Soc Extraction Principes Actif Utilisation d'un extrait de kluyveromyces dans une composition destinee a traiter les manifestations cutanees du vieillissement
JP2008120792A (ja) * 2006-10-16 2008-05-29 Hayashibara Biochem Lab Inc 保湿・整髪作用を有する皮膚及び毛髪用化粧料とその製造方法
JP2012140348A (ja) * 2010-12-28 2012-07-26 Maruzen Pharmaceut Co Ltd 抗炎症剤、抗老化剤、及び育毛剤、並びに化粧料

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05221821A (ja) * 1992-02-12 1993-08-31 Sakamoto Yakuhin Kogyo Kk 皮膚化粧料
CN1235559C (zh) * 1998-03-11 2006-01-11 株式会社创研 皮肤水分保持能力的改善剂
US20030113357A1 (en) * 2000-05-23 2003-06-19 The Procter & Gamble Company Skin Care Compositions
JP5221821B1 (ja) * 2011-07-01 2013-06-26 パナソニック株式会社 撮像装置

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000159653A (ja) * 1998-11-24 2000-06-13 Nonogawa Shoji Kk 皮膚外用剤
FR2826576A1 (fr) * 2001-06-27 2003-01-03 Soc Extraction Principes Actif Utilisation d'un extrait de kluyveromyces dans une composition destinee a traiter les manifestations cutanees du vieillissement
JP2008120792A (ja) * 2006-10-16 2008-05-29 Hayashibara Biochem Lab Inc 保湿・整髪作用を有する皮膚及び毛髪用化粧料とその製造方法
JP2012140348A (ja) * 2010-12-28 2012-07-26 Maruzen Pharmaceut Co Ltd 抗炎症剤、抗老化剤、及び育毛剤、並びに化粧料

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NIKKO CHEMICALS CO., LTD., SHIN KESHOHIN HANDBOOK, 30 October 2006 (2006-10-30), pages 95 - 101 *

Also Published As

Publication number Publication date
CN105263471B (zh) 2018-09-28
WO2015012198A1 (fr) 2015-01-29
CN105263471A (zh) 2016-01-20
TW201507733A (zh) 2015-03-01
HK1213786A1 (zh) 2016-07-15
TWI636797B (zh) 2018-10-01
JP6382815B2 (ja) 2018-08-29
JPWO2015012198A1 (ja) 2017-03-02

Similar Documents

Publication Publication Date Title
KR102156898B1 (ko) 유산균발효 혼합물을 함유하는 피부 미백, 피부 보습, 항산화, 항염, 피부장벽 강화 및 피부흡수 기능을 개선한 섭취 가능한 화장료 조성물
KR102194315B1 (ko) 락토바실러스 람노서스 균주를 접종하여 발효시킨 병풀 발효 추출물을 포함하는 항산화용 또는 피부 마이크로바이옴 균형 유지용 화장료 조성물
KR20180108504A (ko) 초유의 발효산물과 이를 이용한 화장료 조성물
JP6382815B2 (ja) 保湿剤
KR20130023534A (ko) 유자 추출물을 포함하는 피부 각질박리용 화장료 조성물
KR101855207B1 (ko) 흑효모 발효를 통해 비타민 c 함량이 증가된 카카두플럼 추출물을 함유하는 화장료 조성물
KR102270709B1 (ko) 복합 세라마이드 및 천연 추출물을 포함하는 피부개선용 화장료 조성물
TW201010741A (en) Cosmetic composition for anti-aging of the skin comprising phaseolus radiatus extract of fermentation-enzyme treatment
JP2016138099A (ja) 水中油型乳化組成物
JP3184114B2 (ja) 保湿剤
KR101953676B1 (ko) 악마의 발톱 초음파 추출물을 함유하는 피부 보습용 화장료 조성물
CN115813774A (zh) 具有美白效果的水油双层精粹组合物及其制备方法与应用
KR101880470B1 (ko) 유기산 발효액과 천연 고분자 성분을 함유하는 피부 보습용 화장료 조성물
CN112842951B (zh) 二次发酵的桦树汁及其在皮肤外用组合物中的应用
JP6407742B2 (ja) 液状化粧料
TWI701033B (zh) 膠原纖維的集束能增強劑
KR102100820B1 (ko) 프로방스장미꽃잎 흑효모 발효액을 함유하는 화장료 조성물
KR102119622B1 (ko) 수수새싹 추출액의 발효액 또는 이의 발효 추출액을 유효성분으로 함유하는 피부 주름개선용 화장료 조성물 및 그의 제조방법
KR102026366B1 (ko) 복합 프로바이오틱스의 유청 발효물을 포함하는 화장료 조성물, 이의 제조방법 및 이를 포함하는 기능성 화장품
JP2005029546A (ja) α−グルコシダーゼ活性化剤
KR102018512B1 (ko) 단삼 흑효모 발효액을 함유하는 화장료 조성물
KR101363028B1 (ko) 레몬밤, 베르가못, 박하잎, 한련초 및 지구자 추출물을 유효성분으로 함유하는 여드름 예방, 개선 또는 치료용 화장용 조성물
KR101715194B1 (ko) 누룩으로부터 코직산 발현 및 농축추출방법
JP2009102242A (ja) 美白剤、及び美白用皮膚外用剤
KR20160020038A (ko) 프랜지패니 오일 또는 프랜지패니 오일의 발효물을 포함하는 화장료 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13890123

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 13890123

Country of ref document: EP

Kind code of ref document: A1